# Efficacy and Safety of Long Term Use of hCG or hCG Plus hMG in Males With Isolated Hypogonadotropic Hypogonadism (IHH)

> **NCT03687606** · PHASE4 · UNKNOWN · sponsor: **Tongji Hospital** · enrollment: 210 (estimated)

## Conditions studied

- Isolated Hypogonadotropic Hypogonadism
- Kallmann Syndrome
- Infertility

## Interventions

- **DRUG:** Human Chorionic Gonadotropin
- **DRUG:** human menopausal gonadotropin

## Key facts

- **NCT ID:** NCT03687606
- **Lead sponsor:** Tongji Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-10-18
- **Primary completion:** 2024-10-01
- **Final completion:** 2025-10-01
- **Target enrollment:** 210 (ESTIMATED)
- **Last updated:** 2020-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03687606

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03687606, "Efficacy and Safety of Long Term Use of hCG or hCG Plus hMG in Males With Isolated Hypogonadotropic Hypogonadism (IHH)". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03687606. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*